Pharmacokinetics bioequivalence study of KIT-302, containing a lower dosage (2.5 mg) of amlodipine

Trial Profile

Pharmacokinetics bioequivalence study of KIT-302, containing a lower dosage (2.5 mg) of amlodipine

Planning
Phase of Trial: Phase I

Latest Information Update: 19 May 2016

At a glance

  • Drugs Amlodipine/celecoxib (Primary)
  • Indications Hypertension
  • Focus Pharmacokinetics
  • Most Recent Events

    • 19 May 2016 New trial record
    • 10 May 2016 According to Kitov Pharmaceuticals media release, this study is anticipitated to be conducted by the end of 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top